Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction

European Journal of Cardio-thoracic Surgery

Volumn 33, Issue 4, 2008, Pages 645-650

  Boodhwani, Munir ^a   Voisine, Pierre ^a   Ruel, Marc ^a   Sodha, Neel R ^a   Feng, Jun ^a   Xu, Shu Hua ^a   Bianchi, Cesario ^a   Sellke, Frank W ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Endothelial dysfunction; Fibroblast growth factor; Molecular biology; Myocardial ischemia; Vascular endothelial growth factor

Indexed keywords

ADENOSINE DIPHOSPHATE; CHOLESTEROL; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PLACEBO; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL DIET; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; FEEDING; GENETIC ANALYSIS; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HYPERCHOLESTEROLEMIA; INSTRUMENTAL DELIVERY; MICROVASCULATURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REST; STATISTICAL SIGNIFICANCE; SWINE;

ANIMALS; CORONARY ARTERY DISEASE; FIBROBLAST GROWTH FACTOR 2; HYPERCHOLESTEROLEMIA; MODELS, ANIMAL; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; SWINE; SWINE, MINIATURE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 40649087349     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.12.016     Document Type: Article

References (22)

1. Simons M., Bonow R.O., Chronos N.A., Cohen D.J., Giordano F.J., Hammond H.K., Laham R.J., Li W., Pike M., Sellke F.W., Stegmann T.J., Udelson J.E., and Rosengart T.K. Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation 102 (2000) E73-E86
2. Carmeliet P. Angiogenesis in health and disease. Nat Med 9 (2003) 653-660
3. Boodhwani M., Sodha N.R., Laham R.J., and Sellke F.W. The future of therapeutic myocardial angiogenesis. Shock 26 (2006) 332-341
4. Zhang X., Zhao S.P., Li X.P., Gao M., and Zhou Q.C. Endothelium-dependent and -independent functions are impaired in patients with coronary heart disease. Atherosclerosis 149 (2000) 19-24
5. Boodhwani M., Nakai Y., Mieno S., Voisine P., Bianchi C., Araujo E.G., Feng J., Michael K., Li J., and Sellke F.W. Hypercholesterolemia impairs the myocardial angiogenic response in a swine model of chronic ischemia: role of endostatin and oxidative stress. Ann Thorac Surg 81 (2006) 634-641
6. Boodhwani M., Sodha N.R., Mieno S., Xu S.H., Feng J., Ramlawi B., Clements R.T., and Sellke F. Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation 116 11 suppl. (2007) 131-137
7. Jang J.J., Ho H.K., Kwan H.H., Fajardo L.F., and Cooke J.P. Angiogenesis is impaired by hypercholesterolemia: role of asymmetric dimethylarginine. Circulation 102 (2000) 1414-1419
8. Ruel M., Wu G.F., Khan T.A., Voisine P., Bianchi C., Li J., Laham R.J., and Sellke F.W. Inhibition of the cardiac angiogenic response to surgical FGF-2 therapy in a Swine endothelial dysfunction model. Circulation 108 Suppl. 1 (2003) II335-II340
9. Voisine P., Li J., Bianchi C., Khan T.A., Ruel M., Xu S.H., Feng J., Rosinberg A., Malik T., Nakai Y., and Sellke F.W. Effects of l-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction. Circulation 112 (2005) I202-I207
10. Boodhwani M., Sodha N.R., Mieno S., Ramlawi B., Xu S.H., Feng J., Clements R.T., Ruel M., and Sellke F.W. Insulin treatment enhances the myocardial angiogenic response in diabetes. J Thorac Cardiovasc Surg 134 6 (2007) 1453-1460
11. Boodhwani M., Mieno S., Voisine P., Feng J., Sodha N., Li J., and Sellke F.W. High-dose atorvastatin is associated with impaired myocardial angiogenesis in response to vascular endothelial growth factor in hypercholesterolemic swine. J Thorac Cardiovasc Surg 132 (2006) 1299-1306
12. Sellke F.W., Laham R.J., Edelman E.R., Pearlman J.D., and Simons M. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Ann Thorac Surg 65 (1998) 1540-1544
13. Tofukuji M., Metais C., Li J., Franklin A., Simons M., and Sellke F.W. Myocardial VEGF expression after cardiopulmonary bypass and cardioplegia. Circulation 98 (1998) II242-II246 [discussion II247-248]
14. Boodhwani M., Nakai Y., Voisine P., Feng J., Li J., Mieno S., Ramlawi B., Bianchi C., Laham R., and Sellke F.W. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response. Circulation 114 (2006) I402-I408
15. Voisine P., Bianchi C., Ruel M., Malik T., Rosinberg A., Feng J., Khan T.A., Xu S.H., Sandmeyer J., Laham R.J., and Sellke F.W. Inhibition of the cardiac angiogenic response to exogenous vascular endothelial growth factor. Surgery 136 (2004) 407-415
16. Toyota E., Matsunaga T., and Chilian W.M. Myocardial angiogenesis. Mol Cell Biochem 264 (2004) 35-44
17. Zhang Y., Li J., Partovian C., Sellke F.W., and Simons M. Syndecan-4 modulates basic fibroblast growth factor 2 signaling in vivo. Am J Physiol Heart Circ Physiol 284 (2003) H2078-H2082
18. Detillieux K.A., Sheikh F., Kardami E., and Cattini P.A. Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res 57 (2003) 8-19
19. Hughes G.C., Biswas S.S., Yin B., Coleman R.E., DeGrado T.R., Landolfo C.K., Lowe J.E., Annex B.H., and Landolfo K.P. Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF. Ann Thorac Surg 77 (2004) 812-818
20. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87 (2000) 840-844
21. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., and Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88 (1997) 277-285
22. Cudmore M., Ahmad S., Al-Ani B., Hewett P., Ahmed S., and Ahmed A. VEGF-E activates endothelial nitric oxide synthase to induce angiogenesis via cGMP and PKG-independent pathways. Biochem Biophys Res Commun 345 (2006) 1275-1282